Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80,110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Zi Shen Huo Luo Formula Enhances the Therapeutic Effects of Angiotensin-Converting Enzyme Inhibitors on Hypertensive Left Ventricular Hypertrophy by Interfering With Aldosterone Breakthrough and Affecting Caveolin-1/Mineralocorticoid Receptor Colocalization and Downstream Extracellular Signal-Regulated Kinase Signaling.
Song X, Zhao Y, Wang S, Wang Y, Chen Q, Zhao H, Wang H, Tian S, Yu H, Wu Z. Song X, et al. Among authors: zhao h, zhao y. Front Pharmacol. 2020 Apr 3;11:383. doi: 10.3389/fphar.2020.00383. eCollection 2020. Front Pharmacol. 2020. PMID: 32317965 Free PMC article.
Zi Shen Huo Luo Formula Prevents Aldosterone-Induced Cardiomyocyte Hypertrophy and Cardiac Fibroblast Proliferation by Regulating the Striatin-Mediated MR/EGFR/ERK Signaling Pathway.
Feng W, Zhao Y, Song X, Wang Y, Chen Q, Zhao H, Lu G, Yuan H, Wu Z, Yu H. Feng W, et al. Among authors: zhao h, zhao y. Evid Based Complement Alternat Med. 2020 Sep 16;2020:9028047. doi: 10.1155/2020/9028047. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33014117 Free PMC article.
80,110 results
You have reached the last available page of results. Please see the User Guide for more information.